Neulasta-controlled

pegfilgrastim control agent

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Neulasta-controlled, covering 2021-05-07 to 2021-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Phase 3]